Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jefson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Surgical Endoscopy|August 1, 1997
Duration of postlaparoscopic pneumoperitoneumK Draper, R Jefson, R Jongeward, et al.
The Journal of Antibiotics|November 1, 1989
UK-69,753, a novel member of the efrotomycin family of antibiotics. II. Structure determination and biological activityM R Jefson, J Bordner, C P Reese, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzymeS J Froelich-Ammon, P R McGuirk, T D Gootz, et al.
The Journal of Antibiotics|October 1, 1989
UK-69,753, a novel member of the efrotomycin family of antibiotics. I. Taxonomy of the producing organism, fermentation and isolationM S Pacey, M R Jefson, L H Huang, et al.
Journal of Medicinal Chemistry|February 21, 1992
Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicineP R McGuirk, M R Jefson, D D Mann, et al.
Journal of Medicinal Chemistry|March 14, 1997
Repromicin derivatives with potent antibacterial activity against Pasteurella multocidaJ W McFarland, S J Hecker, B H Jaynes, et al.
Journal of Medicinal Chemistry|April 25, 1997
Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocidaJ W McFarland, C M Berger, S A Froshauer, et al.
Bioorganic & Medicinal Chemistry|July 6, 2016
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitorsFlorence F Wagner, Michel Weïwer, Stefan Steinbacher, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Surgical Endoscopy|August 1, 1997
Duration of postlaparoscopic pneumoperitoneumK Draper, R Jefson, R Jongeward, et al.
The Journal of Antibiotics|November 1, 1989
UK-69,753, a novel member of the efrotomycin family of antibiotics. II. Structure determination and biological activityM R Jefson, J Bordner, C P Reese, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzymeS J Froelich-Ammon, P R McGuirk, T D Gootz, et al.
The Journal of Antibiotics|October 1, 1989
UK-69,753, a novel member of the efrotomycin family of antibiotics. I. Taxonomy of the producing organism, fermentation and isolationM S Pacey, M R Jefson, L H Huang, et al.
Journal of Medicinal Chemistry|February 21, 1992
Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicineP R McGuirk, M R Jefson, D D Mann, et al.
Journal of Medicinal Chemistry|March 14, 1997
Repromicin derivatives with potent antibacterial activity against Pasteurella multocidaJ W McFarland, S J Hecker, B H Jaynes, et al.
Journal of Medicinal Chemistry|April 25, 1997
Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocidaJ W McFarland, C M Berger, S A Froshauer, et al.
Bioorganic & Medicinal Chemistry|July 6, 2016
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitorsFlorence F Wagner, Michel Weïwer, Stefan Steinbacher, et al.
Pageof 1